I
Ilona T. Goldfarb
Researcher at Harvard University
Publications - 58
Citations - 1468
Ilona T. Goldfarb is an academic researcher from Harvard University. The author has contributed to research in topics: Pregnancy & Medicine. The author has an hindex of 14, co-authored 45 publications receiving 659 citations. Previous affiliations of Ilona T. Goldfarb include University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.
Kathryn J. Gray,Evan A. Bordt,Caroline Atyeo,Elizabeth A DeRiso,Babatunde Akinwunmi,Nicola Young,Aranxta Medina Baez,Lydia L. Shook,Dana Cvrk,Kaitlyn E. James,Rose M. De Guzman,Sara Brigida,Khady Diouf,Ilona T. Goldfarb,Lisa M. Bebell,Lael M. Yonker,Alessio Fasano,S. Alireza Rabi,Michal A. Elovitz,Galit Alter,Andrea G. Edlow +20 more
TL;DR: In this paper, the authors evaluated the immunogenicity and reactogenicity of coronavirus disease 2019 messenger RNA vaccination in pregnant and lactating women compared with: (1) non-pregnant controls and (2) natural infection in pregnancy.
Journal ArticleDOI
Compromised SARS-CoV-2-specific placental antibody transfer.
Caroline Atyeo,Caroline Atyeo,Krista M. Pullen,Evan A. Bordt,Stephanie Fischinger,Stephanie Fischinger,John F. Burke,Ashlin R. Michell,Matthew D. Slein,Carolin Loos,Carolin Loos,Lydia L. Shook,Adeline A. Boatin,Laura J. Yockey,David Pépin,Marie-Charlotte Meinsohn,Ngoc Minh Phuong Nguyen,Maeva Chauvin,Drucilla J. Roberts,Ilona T. Goldfarb,Juan D. Matute,Kaitlyn E. James,Lael M. Yonker,Lisa M. Bebell,Anjali J Kaimal,Kathryn J. Gray,Douglas A. Lauffenburger,Andrea G. Edlow,Galit Alter +28 more
TL;DR: Systems serology characterized the Fc-profile of influenza, pertussis, and SARS-CoV-2-specific antibodies transferred across the placenta to point to unexpected compensatory mechanisms to boost immunity in neonates, providing insights for maternal vaccine design.
Journal ArticleDOI
Fc Glycan-Mediated Regulation of Placental Antibody Transfer
Madeleine F. Jennewein,Ilona T. Goldfarb,Sepideh Dolatshahi,Sepideh Dolatshahi,Cormac Cosgrove,Francesca Fj Noelette,Marina Krykbaeva,Jishnu Das,Jishnu Das,Aniruddh Sarkar,Aniruddh Sarkar,Matthew J. Gorman,Stephanie Fischinger,Carolyn M. Boudreau,Joelle Brown,Jennifer H. Cooperrider,Jasneet Aneja,Todd J. Suscovich,Barney S. Graham,Georg M. Lauer,Tessa Goetghebuer,Arnaud Marchant,Douglas A. Lauffenburger,Arthur Y. Kim,Laura E. Riley,Galit Alter +25 more
TL;DR: Insight is provided for the development of next-generation maternal vaccines designed to elicit antibodies that will most effectively aid neonates by using systems serology to define Fc features associated with antibody transfer.
Posted ContentDOI
COVID-19 vaccine response in pregnant and lactating women: a cohort study.
Kathryn J. Gray,Evan A. Bordt,Caroline Atyeo,Caroline Atyeo,Elizabeth A DeRiso,Babatunde Akinwunmi,Nicola Young,Aranxta Medina Baez,Lydia L. Shook,Dana Cvrk,Kaitlyn E. James,Rose M. De Guzman,Sara Brigida,Khady Diouf,Ilona T. Goldfarb,Lisa M. Bebell,Lael M. Yonker,Alessio Fasano,Sayed A Rabi,Michal A. Elovitz,Galit Alter,Andrea G. Edlow +21 more
TL;DR: In this article, the authors evaluated the immunogenicity and reactogenicity of COVID-19 mRNA vaccination in pregnant and lactating women compared to: (1) non-pregnant controls and (2) natural CoV-19 infection in pregnancy.
Journal ArticleDOI
Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19.
Richard M. Burwick,Sigal Yawetz,Sigal Yawetz,Kathryn E. Stephenson,Kathryn E. Stephenson,Ai-ris Y. Collier,Ai-ris Y. Collier,Pritha Sen,Brian G. Blackburn,E Milunka Kojic,Adi Hirshberg,Jose F. Suarez,Magdalena E. Sobieszczyk,Kristen M. Marks,Shawn Mazur,Cecilia Big,Oriol Manuel,Gregory Morlin,Suzanne J Rose,Mariam Naqvi,Ilona T. Goldfarb,Adam DeZure,Laura Telep,Susanna K Tan,Yang Zhao,Tom Hahambis,Jason Hindman,Anand P Chokkalingam,Christoph C Carter,Moupali Das,Anu Osinusi,Diana M. Brainard,Tilly A. Varughese,Olga A. Kovalenko,Matthew D Sims,Samit Desai,Geeta K. Swamy,Jeanne S. Sheffield,Rebecca Zash,Rebecca Zash,William R. Short +40 more
TL;DR: Among 86 pregnant and postpartum women with severe COVID-19 who received compassionate-use remdesivir, recovery rates were high, with a low rate of serious AEs.